Video Library

Identifying and Solving Top Challenges to Oncology Biomarker Testing

Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of [ Read More ]

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Overcoming Challenges to Molecular Biomarker Testing

Drs. Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges in biomarker testing—tissue stewardship and complexity of biomarker tests and results—and ways to overcome these challenges—improved communication among all members of the cancer care team and simplification of biomarker test results to focus on actionable biomarkers.

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Impact of Reimbursement for Biomarker Testing on Clinical Practice

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Navigating the CMS 14-Day Rule in Biomarker Testing

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Immunotherapy vs Targeted Therapy

Dr Morganna Freeman explains the difference between immunotherapies and targeted therapies in plain language for patients to easily understand.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Dealing with Misinformation

Dr Morganna Freeman addresses the issue of the pervasiveness of misinformation on the Internet.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear and Video Library

Understanding Immunotherapy

Dr Morganna Freeman breaks down her methods for explaining immunotherapy to her patients.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

The Evolving Field of Treatment Modalities

Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Changing the Conversation: Immunotherapy and Long-Term Survival

Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Sign me up!